139 related articles for article (PubMed ID: 21991850)
1. [Serum chitotriosidase activity as a biomarker of pulmonary sarcoidosis].
Gołab K; Passowicz-Muszyńska E; Jankowska R; Warwas M
Pol Merkur Lekarski; 2011 Sep; 31(183):179-82. PubMed ID: 21991850
[TBL] [Abstract][Full Text] [Related]
2. Human chitotriosidase: a potential new marker of sarcoidosis severity.
Bargagli E; Maggiorelli C; Rottoli P
Respiration; 2008; 76(2):234-8. PubMed ID: 18487875
[TBL] [Abstract][Full Text] [Related]
3. Chitotriosidase activity in the serum of patients with sarcoidosis and pulmonary tuberculosis.
Bargagli E; Margollicci M; Nikiforakis N; Luddi A; Perrone A; Grosso S; Rottoli P
Respiration; 2007; 74(5):548-52. PubMed ID: 17347558
[TBL] [Abstract][Full Text] [Related]
4. Plasma chitotriosidase and CCL18 as surrogate markers for granulomatous macrophages in sarcoidosis.
Boot RG; Hollak CE; Verhoek M; Alberts C; Jonkers RE; Aerts JM
Clin Chim Acta; 2010 Jan; 411(1-2):31-6. PubMed ID: 19808030
[TBL] [Abstract][Full Text] [Related]
5. Chitotriosidase activity in patients with interstitial lung diseases.
Bargagli E; Margollicci M; Luddi A; Nikiforakis N; Perari MG; Grosso S; Perrone A; Rottoli P
Respir Med; 2007 Oct; 101(10):2176-81. PubMed ID: 17631992
[TBL] [Abstract][Full Text] [Related]
6. Chitotriosidase and soluble IL-2 receptor: comparison of two markers of sarcoidosis severity.
Bargagli E; Bianchi N; Margollicci M; Olivieri C; Luddi A; Coviello G; Grosso S; Rottoli P
Scand J Clin Lab Invest; 2008; 68(6):479-83. PubMed ID: 18609101
[TBL] [Abstract][Full Text] [Related]
7. Chitotriosidase activity in sarcoidosis and some other pulmonary diseases.
Tercelj M; Salobir B; Simcic S; Wraber B; Zupancic M; Rylander R
Scand J Clin Lab Invest; 2009; 69(5):575-8. PubMed ID: 19347743
[TBL] [Abstract][Full Text] [Related]
8. Serum chitotriosidase activity in acute appendicitis: preliminary results.
Acar A; Keskek M; Işman FK; Kucur M; Tez M
Am J Emerg Med; 2012 Jun; 30(5):775-7. PubMed ID: 21641156
[TBL] [Abstract][Full Text] [Related]
9. Serum chitotriosidase activity, a marker of activated macrophages, predicts new cardiovascular events independently of C-reactive protein.
Artieda M; Cenarro A; Gañán A; Lukic A; Moreno E; Puzo J; Pocoví M; Civeira F
Cardiology; 2007; 108(4):297-306. PubMed ID: 17290100
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of chitotriosidase as a marker of disease activity and clinical stage in sarcoidosis.
Grosso S; Margollicci MA; Bargagli E; Buccoliero QR; Perrone A; Galimberti D; Morgese G; Balestri P; Rottoli P
Scand J Clin Lab Invest; 2004; 64(1):57-62. PubMed ID: 15025429
[TBL] [Abstract][Full Text] [Related]
11. Pathology of sarcoidosis.
Rosen Y
Semin Respir Crit Care Med; 2007 Feb; 28(1):36-52. PubMed ID: 17330191
[TBL] [Abstract][Full Text] [Related]
12. Chitotriosidase as a marker of disease activity in sarcoidosis.
Brunner J; Scholl-Bürgi S; Zimmerhackl LB
Rheumatol Int; 2007 Oct; 27(12):1171-2. PubMed ID: 17534622
[TBL] [Abstract][Full Text] [Related]
13. [Serum activity of chitotriosidase, lysozyme and cathepsin H in patients with lung cancer and patients with inflammatory exudate (preliminary report)].
Gołab K; Passowicz-Muszyńska E; Jankowska R; Warwas M
Pol Merkur Lekarski; 2009 Mar; 26(153):194-7. PubMed ID: 19388531
[TBL] [Abstract][Full Text] [Related]
14. Chitotriosidase as a marker of disease activity in sarcoidosis.
Brunner J; Scholl-Bürgi S; Prelog M; Zimmerhackl LB
Rheumatol Int; 2007 Oct; 27(12):1185-6. PubMed ID: 17252260
[TBL] [Abstract][Full Text] [Related]
15. Sarcoidosis: a primary care review.
Belfer MH; Stevens RW
Am Fam Physician; 1998 Dec; 58(9):2041-50, 2055-6. PubMed ID: 9861878
[TBL] [Abstract][Full Text] [Related]
16. The role of serum and bronchoalveolar lavage fluid chitotriosidase activity on diagnosis, disease characteristics and prognosis of sarcoidosis.
Köycü Buhari G; Çiledağ A; Kurt İ; Çağlar E; Kaya A; Özdemir Kumbasar Ö; Çelik G
Tuberk Toraks; 2023 Dec; 71(4):367-377. PubMed ID: 38152007
[TBL] [Abstract][Full Text] [Related]
17. Plasma chitotriosidase in male Fabry patients: a marker for monitoring lipid-laden macrophages and their correction by enzyme replacement therapy.
Vedder AC; Cox-Brinkman J; Hollak CE; Linthorst GE; Groener JE; Helmond MT; Scheij S; Aerts JM
Mol Genet Metab; 2006 Nov; 89(3):239-44. PubMed ID: 16765076
[TBL] [Abstract][Full Text] [Related]
18. Human chitotriosidase: a sensitive biomarker of sarcoidosis.
Bargagli E; Bennett D; Maggiorelli C; Di Sipio P; Margollicci M; Bianchi N; Rottoli P
J Clin Immunol; 2013 Jan; 33(1):264-70. PubMed ID: 22878841
[TBL] [Abstract][Full Text] [Related]
19. Increased chitotriosidase activity in serum of leprosy patients: association with bacillary leprosy.
Iyer A; van Eijk M; Silva E; Hatta M; Faber W; Aerts JM; Das PK
Clin Immunol; 2009 Jun; 131(3):501-9. PubMed ID: 19307157
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis, pathogenesis, and treatment of sarcoidosis.
Sharma OP; Alam S
Curr Opin Pulm Med; 1995 Sep; 1(5):392-400. PubMed ID: 9363101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
